Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
Open accessThe DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
The only causative treatment for IgE-mediated allergies is allergen-specific immunotherapy. However, fewer than 5% of allergy patients receive immunotherapy because of its long duration and risk of allergic side effects. We aimed at enhancing s.c. immunotherapy by direct administration of allergen into s.c. lymph nodes. The objective was to evaluate safety and efficacy compared with conventional s.c. immunotherapy. In a monocentric open-label trial, 165 patients with grass pollen-induced rhinoconjunctivitis were randomized to receive either 54 s.c. injections with pollen extract over 3 years [cumulative allergen dose 4,031,540 standardized quality units (SQ-U)] or 3 intralymphatic injections over 2 months (cumulative allergen dose 3,000 SQ-U). Patients were evaluated after 4 months, 1 year, and 3 years by nasal provocation, skin prick testing, IgE measurements, and symptom scores. Three low-dose intralymphatic allergen administrations increased tolerance to nasal provocation with pollen already within 4 months ( P < 0.001). Tolerance was long lasting and equivalent to that achievable after standard s.c. immunotherapy ( P = 0.291 after 3 years). Intralymphatic immunotherapy ameliorated hay fever symptoms ( P < 0.001), reduced skin prick test reactivity ( P < 0.001), decreased specific serum IgE ( P < 0.001), caused fewer adverse events than s.c. immunotherapy ( P = 0.001), enhanced compliance ( P < 0.001), and was less painful than venous puncture ( P = 0.018). In conclusion, intralymphatic allergen administration enhanced safety and efficacy of immunotherapy and reduced treatment time from 3 years to 8 weeks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The major advantages of this route of allergen application are the markedly reduced duration of immunotherapy treatment (both time spent and number of visits) and the much lower amount of allergen required to achieve results.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“Clinical trials have illustrated that a reduction in AR symptoms can be achieved with just 3 doses of injected allergen, with a dosage interval of 1 month1716-1720 (Table IX.D.6).”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“In 2008, Senti et al.1716 compared ILIT to SCIT and not to placebo.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“Most trials1716,1718-1721 used commercially available grass pollen or birch pollen allergen extract as the antigen.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
In the citing paper
“Of the 6 trials published thus far, 5 have demonstrated clinical efficacy and safety.1716-1720”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1716]
Citations
Cites
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R., & Malling, H.-J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,581
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E.-M., Jacobson, M. R., O'Brien, F., Noble, W., Till, S. J., Hamid, Q. A., & Nouri-Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,373
Möller, C., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Jacobsen, L., Koivikko, A., Koller, D. Y., Niggemann, B., Norberg, L. A., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121317 · Cited by 1,065
Position Paper: Allergen standardization and skin tests
Dreborg, S., & Frew, A. (1993) · Allergy · doi:10.1111/j.1398-9995.1993.tb04756.x · Cited by 753
Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases
Bousquet, J., Lockey, R., Malling, H. J., Alvarez-Cuesta, E., Canonica, G. W., Chapman, M. D., Creticos, P. J., Dayer, J. M., Durham, S. R., Demoly, P., et al. (1998) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63136-5 · Cited by 736
Arbes Jr., S. J., Gergen, P. J., Elliott, L., & Zeldin, D. C. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.017 · Cited by 639 · cited 1×
“I allergies, such as allergic rhinoconjunctivitis and asthma, have become highly prevalent, affecting up to 35% of the population in westernized countries (1).”
BackgroundPajno, G. B., Barberio, G., De Luca, F., Morabito, L., & Parmiani, S. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01161.x · Cited by 546
Varney, V. A., Gaga, M., Frew, A. J., Aber, V. R., Kay, A. B., & Durham, S. R. (1991) · BMJ · doi:10.1136/bmj.302.6771.265 · Cited by 384
Fibroblasts as Efficient Antigen-Presenting Cells in Lymphoid Organs
Kündig, T. M., Bachmann, M. F., DiPaolo, C., Simard, J. J. L., Battegay, M., Lother, H., Gessner, A., Kühlcke, K., Ohashi, P. S., Hengartner, H., et al. (1995) · Science · doi:10.1126/science.7761853 · Cited by 301
Self-citation(1993) · PubMed · Cited by 221
Research works printed but not linked: 1
- Epidemiology Surveys and Danske Equities (ALK-Abelló, Hørsholm, Denmark, 2005).
Cited by
Items 201–300 of 363
Investigational drugs for the treatment of allergic rhinitis
Castillo, J. C. M., & Dimov, V. V. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.907271 · Cited by 13
Novel Approaches to Allergen Immunotherapy for Respiratory Allergies
Lao‐Araya, M. (2024) · Pharmaceuticals · doi:10.3390/ph17111510 · Cited by 13
New modalities of allergen immunotherapy
Ramesh, M., & Karagic, M. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1502126 · Cited by 13
Immunotherapy of allergic disease
Frew, A. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3691-1.00104-5 · Cited by 10
Dosing intervals in intralymphatic immunotherapy
Hjálmsdóttir, Á., Waeckerle‐Men, Y., Duda, A., Kündig, T. M., & Johansen, P. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12657 · Cited by 10
Self-citationThe efficiency of peptide immunotherapy for respiratory allergy
Incorvaia, C., Montagni, M., & Ridolo, E. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1157017 · Cited by 12
Allergen Immunotherapy for Birch Pollen-Allergic Patients: Recent Advances
Moingeon, P. E., Floch, V. B., Airouche, S., Baron‐Bodo, V., Nony, E., & Mascarell, L. (2016) · Immunotherapy · doi:10.2217/imt-2015-0027 · Cited by 11
GAD65: a prospective vaccine for treating Type 1 diabetes?
Ludvigsson, J. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1328495 · Cited by 10
Taketomi, E. A., Miranda, J. S., Cunha-Junior, J. P., & Silva, D. A. O. (2017) · InTech eBooks · doi:10.5772/66711 · Cited by 13
Next generation immunotherapy for tree pollen allergies
Su, Y. A., Romeu-Bonilla, E., & Heiland, T. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1367882 · Cited by 14
Linking autoantigen properties to mechanisms of immunity
Griffin, J. D., Song, J. Y., Sestak, J. O., DeKosky, B. J., & Berkland, C. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.005 · Cited by 12
Spatial delivery of immune cues to lymph nodes to define therapeutic outcomes in cancer vaccination
Andorko, J. I., Tsai, S. J., Gammon, J. M., Carey, S. T., Zeng, X., Gosselin, E. A., Edwards, C., Shah, S., Hess, K. L., & Jewell, C. M. (2022) · Biomaterials Science · doi:10.1039/d2bm00403h · Cited by 9
Specific immunotherapy for allergic rhinitis in children
Wang, C., & Zhang, L. (2014) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0000000000000101 · Cited by 10
The use of nasal allergen vs allergen exposure chambers to evaluate allergen immunotherapy
Hossenbaccus, L., & Ellis, A. K. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1905523 · Cited by 12
Therapeutic Effects and Biomarkers in Sublingual Immunotherapy: A Review
Fujimura, T., Okamoto, Y., & Taniguchi, M. (2012) · Journal of Allergy · doi:10.1155/2012/381737 · Cited by 11
AIT: New Avenues in Allergen Immunotherapy
Pfützner, W., & Möbs, C. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_514 · Cited by 10
Allergen immunotherapy: progress and future outlook
Šošić, L., Paolucci, M., Flory, S., Jebbawi, F., Kündig, T. M., & Johansen, P. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2209319 · Cited by 15
Self-citationSpezifische Immuntherapie und atopische Dermatitis: Was gibt es Neues?
Novak, N., & Werfel, T. (2011) · Der Hautarzt · doi:10.1007/s00105-011-2158-1 · Cited by 9
Adlany, Y. K., Šošić, L., Senti, G., Lang, C. C. V., Wüthrich, B., Kündig, T. M., & Johansen, P. (2023) · Journal of Allergy and Clinical Immunology: Global · doi:10.1016/j.jacig.2022.09.007 · Cited by 9
Self-citationStrategies and delivery systems for cell-based therapy in autoimmunity
Puccetti, M., Costantini, C., Schoubben, A., Giovagnoli, S., & Ricci, M. (2024) · Frontiers in Drug Delivery · doi:10.3389/fddev.2024.1436842 · Cited by 8
Graner, A., Mueller, R. S., Geisler, J., Bogenstätter, D., White, S., Jónsdóttir, S., & Marti, E. (2024) · Frontiers in Allergy · doi:10.3389/falgy.2024.1467245 · Cited by 8
Potential Cost Savings by Switching from Subcutaneous to Intralymphatic Insect Venom Immunotherapy
Chabot, A., Lang, C. C. V., Kündig, T. M., Schmid‐Grendelmeier, P., & Johansen, P. (2023) · International Archives of Allergy and Immunology · doi:10.1159/000531332 · Cited by 9
Self-citationImmunology of allergen immunotherapy
Rahman, R., & Wesemann, D. R. (2022) · Immunotherapy Advances · doi:10.1093/immadv/ltac022 · Cited by 10
Allergen-Specific Immunotherapy
Steveling, E. H. (2016) · European Medical Journal · doi:10.33590/emj/10314632 · Cited by 37
Vaccines: could asthma in young children be a preventable disease?
Elenius, V., & Jartti, T. T. (2016) · Pediatric Allergy and Immunology · doi:10.1111/pai.12598 · Cited by 9
Fritzsching, B. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00031 · Cited by 9
Allergic rhinitis management: what’s next?
Tabatabaian, F., & Casale, T. B. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1438270 · Cited by 9
Thomas, W. R. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03232.x · Cited by 8
Low‐dose DNA vaccination into the submandibular lymph nodes in ponies
Landolt, G. A., Hussey, S. B., Kreutzer, K., Quintana, A. M., & Lunn, D. P. (2010) · Veterinary Record · doi:10.1136/vr.c3891 · Cited by 8
A critical appraisal of analyzing nasal provocation test results in allergen immunotherapy trials
Graf, N., Dinkel, B., Rose, H., Hothorn, L. A., Gerhard, D., Johansen, P., Kündig, T. M., Klimek, L., & Senti, G. (2014) · Rhinology Journal · doi:10.4193/rhin13.145 · Cited by 7
Self-citationFuture directions in allergen immunotherapy
Nelson, H. S. (2022) · Allergy and Asthma Proceedings · doi:10.2500/aap.2022.43.210098 · Cited by 7
Wang, W., Wang, X., Wang, H., & Wang, X. (2023) · International Archives of Allergy and Immunology · doi:10.1159/000529025 · Cited by 8
Immunothérapie allergénique dans le traitement de l’allergie aux pollens
Mailhol, C., & Didier, A. P. (2012) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2012.07.005 · Cited by 7
Grass Pollen Immunotherapy: Where are We Now
Würtzen, P. A., Gupta, S., Brand, S., & Andersen, P. S. (2016) · Immunotherapy · doi:10.2217/imt.16.1 · Cited by 7
Fukuda, K., Ishida, W., Wakasa, Y., Takagi, H., Takaiwa, F., & Fukushima, A. (2018) · Cornea · doi:10.1097/ico.0000000000001758 · Cited by 10
Parenteral Vaccine Administration: Tried and True
Johansen, P., & Kündig, T. M. (2014) · Advances in delivery science and technology · doi:10.1007/978-1-4939-1417-3_14 · Cited by 10
Self-citationImmunotherapy of Allergic Disease
Frew, A. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00091-0 · Cited by 9
Nencini, F., Pratesi, S., Petroni, G., Filì, L., Cardilicchia, E., Casini, A., Occhiato, E. G., Calosi, L., Bani, D., Romagnani, S., et al. (2015) · Immunology · doi:10.1111/imm.12475 · Cited by 7
Allergen immunotherapy: what’s new, what’s next?
Nelson, H. S. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1062726 · Cited by 7
Allergen immunotherapy: 100 years, but it does not look like.
Frati, F., Incorvaia, C., Lombardi, C., & Senna, G. (2012) · PubMed · Cited by 7
Gu, T., Zhang, W., Tan, L., Xiang, R., Liu, P., Huang, J., Deng, Q., Deng, Y., Tao, Z., Chen, S., et al. (2025) · Research · doi:10.34133/research.0573 · Cited by 11
Specific immunotherapy in grass pollen allergy
Mailhol, C., & Didier, A. P. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22357 · Cited by 8
van Amersfort, K., Vernooij, J. C. M., & der Lee, A. J. (2023) · Veterinary Dermatology · doi:10.1111/vde.13165 · Cited by 6
Mucosal Immunity and Sublingual Immunotherapy in Respiratory Disorders
Bahçeciler, N. N. (2012) · Journal of Allergy · doi:10.1155/2012/725719 · Cited by 6
Creticos, P. S. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.08.010 · Cited by 8
Orphan immunotherapies for allergic diseases
Ridolo, E., Montagni, M., Incorvaia, C., Senna, G., & Passalacqua, G. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2015.12.031 · Cited by 8
Investigational drugs for allergic rhinitis
Passalacqua, G., Compalati, E., & Canonica, G. W. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903435647 · Cited by 6
Malling, H., Witten, M., & Poulsen, L. K. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.11.037 · Cited by 6
Advances in Allergen Immunotherapy and Safety
Al‐Shouli, S. T. (2025) · Vaccines · doi:10.3390/vaccines13030221 · Cited by 6
Zhu, J., Sun, Y., Qian, X., Li, L., Liu, F., Wang, X., Ke, Y., Shao, J., Zhu, L., Wang, L., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.041 · Cited by 7
Schendzielorz, P., & Klimek, L. (2013) · HNO · doi:10.1007/s00106-013-2730-3 · Cited by 6
Qin, Y., Huang, W., Zheng, R., Wang, Q., Yu, Q., Li, Y., Wang, K., & Tang, J. (2024) · Clinical and Translational Allergy · doi:10.1002/clt2.12341 · Cited by 4
Patients’ perspective on allergen immunotherapy for respiratory allergy
Catamerò, F., Barbaglia, S., Heffler, E. M., Giovannini, M., & Paoletti, G. (2025) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000001110 · Cited by 5
Is intralymphatic immunotherapy effective and safe for allergic rhinitis?: A meta-analysis
Liu, L., Liang, Y., Yan, L., & Li, Z. (2024) · Medicine · doi:10.1097/md.0000000000040589 · Cited by 5
Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunity
Kapnick, S. M., Gosselin, E. A., Tsai, S. J., Oakes, R. S., Habibabady, Z. A., Ackun‐Farmmer, M. A., Carey, S. T., Shah, S., Shen, R., Froimchuk, E., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2409563122 · Cited by 6
Spezifische Immuntherapie im Kindesalter: Subkutane oder sublinguale Applikation
Kopp, M., & Bendiks, M. (2013) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-012-2804-4 · Cited by 5
Development in therapeutic strategies for allergic conjunctivitis
Singh, N., Mazumder, R., Monika, M., Sakshi, S., Khan, F., & Kumar, B. (2023) · Trends in Immunotherapy · doi:10.24294/ti.v7.i1.2025 · Cited by 4
Burks, A. W., Calderón, M. A., Casale, T. B., Cox, L., Demoly, P. M., Jutel, M., Nelson, H. S., & Akdiş, C. A. (2013) · Revue française d'allergologie · doi:10.1016/j.reval.2013.10.001 · Cited by 4
Bernstein, D. I., Blaiss, M. S., Cox, L., Finegold, I., Lanier, B. Q., Nelson, H. S., & Wallace, D. V. (2011) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2011.05.026 · Cited by 4
Pratesi, S., Nencini, F., Filì, L., Occhiato, E. G., Romagnani, S., Parronchi, P., Maggi, E., & Vultaggio, A. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.07.011 · Cited by 4
Alternatives to Subcutaneous Immunotherapy for Allergic Rhinitis
Terada, T., & Kawata, R. (2022) · Allergies · doi:10.3390/allergies2010003 · Cited by 4
Glutamic acid decarboxylase immunotherapy for type 1 diabetes
Ludvigsson, J. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000748 · Cited by 4
Intralymphatic allergen-specific immunotherapy
Kang, S., Jung, J. H., Lee, S. M., & Lee, S. P. (2020) · Allergy Asthma & Respiratory Disease · doi:10.4168/aard.2020.8.2.53 · Cited by 4
Pereira, C., Loureiro, G., Martinho, A., Paiva, A. A., Tavares, B., Machado, D., Nunes, R. C. V., Pedreira, S., Henriques, A., Pais, M. L., et al. (2012) · PubMed · Cited by 6
Allergen‐Specific Immunotherapy
Diesel, A. B. (2013) · doi:10.1002/9781118738818.ch36 · Cited by 4
Breaking the mold: nontraditional approaches to allergen immunotherapy for environmental allergens
Ramchandani, R., Lucyshyn, R., Linton, S., & Ellis, A. K. (2024) · Immunotherapy · doi:10.1080/1750743x.2024.2408216 · Cited by 3
Chemical therapies, immunotherapy, and new treatment strategies for allergic asthma
Sarkar, A., Narala, S. R., Panati, K., & Narala, V. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15502-4.00006-9 · Cited by 3
What Do We Really Know About Intralymphatic Immunotherapy?
Klimek, L., Senti, G., Hoffmann, H. J., & Kündig, T. M. (2018) · Current Treatment Options in Allergy · doi:10.1007/s40521-018-0180-6 · Cited by 3
Self-citationA critical appraisal of analyzing nasal provocation test results in allergen immunotherapy trials
Graf, N., Dinkel, B., Rose, H., Hothorn, L. A., Gerhard, D., Johansen, P., Kuendig, T., Klimek, L., & Senti, G. (2014) · Rhinology Journal · doi:10.4193/rhino13.145 · Cited by 4
Self-citationEmerging concepts of sublingual immunotherapy for allergy
Theodoropoulos, D. S., Morris, M. S., & Morris, D. L. (2009) · Drugs of today · doi:10.1358/dot.2009.45.10.1436883 · Cited by 3
Magrone, T., Magrone, M., & Jirillo, E. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666191202121644 · Cited by 3
Rekombinante Allergene, Peptide und Virus-like Particles in der Immuntherapie von Allergien
Holzhauser, T., Schuler, F., Dudek, S., Kaul, S., Vieths, S., & Mahler, V. (2020) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-020-03231-7 · Cited by 6
Allergenspezifische Immuntherapie bei Rhinitis allergica: Neue Applikationsformen
Klimek, L., Kündig, T. M., & Senti, G. (2015) · HNO · doi:10.1007/s00106-015-0003-z · Cited by 3
Self-citationImmunotherapy Update: What Delivery Techniques Are Available?
Mims, J. “. (2022) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-022-00394-6 · Cited by 3
Allergen Specific Immunotherapy
Çekiç, Ş., & Sapan, N. (2015) · Güncel Pediatri · doi:10.4274/jcp.02419 · Cited by 4
Allergen‐Specific Immunotherapy
Mueller, R. S. (2013) · doi:10.1002/9781118738818.ch12 · Cited by 3
Co-localization of lymph node therapeutics enhances T cell activation and anti-tumor response
Shen, R., Kapnick, S. M., Edwards, C., McIlvaine, R. A., Bridgeman, C. J., Carey, S. T., & Jewell, C. M. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123786 · Cited by 4
Oligonucleotide based-strategies for allergy with special reference to siRNA
Suzuki, M., Zheng, X., Zhang, X., Ichim, T. E., Beduhn, M., & Min, W. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590902841924 · Cited by 2
Immunothérapies innovantes des maladies allergiques respiratoires
Demoly, P. M., Chiriac, A. M., & Michel, F. B. (2016) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30731-9 · Cited by 2
The postnatal development of the compartments in human lymph nodes up to 15 years of age
Pabst, R., Debertin, A. S., Todt-Brenneke, M., Herden, A., & Schmiedl, A. (2023) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2023.152140 · Cited by 2
Specific Immunotherapy and Central Immune System
Pereira, C., Loureiro, G., Tavares, B., & Botelho, F. (2012) · InTech eBooks · doi:10.5772/26354 · Cited by 6
Novel Vaccines for Type I Allergy
Scheiblhofer, S., Thalhamer, J., & Weiss, R. (2013) · Springer eBooks · doi:10.1007/978-3-319-00978-0_4 · Cited by 3
Allergen immunotherapy: Basic concepts
Kant, S., Hassan, G., Prakash, V., Verma, A., Saheer, S., Singh, A., Singh, A., Jena, N. N., & Wani, N. (2013) · Indian Journal of Allergy Asthma and Immunology · doi:10.4103/0972-6691.116606 · Cited by 2
Allergen Preparation in AIT, Now and in the Future
Yang, L., & Zhu, R. (2021) · Current Treatment Options in Allergy · doi:10.1007/s40521-021-00281-3 · Cited by 2
Allergic Disease - New Developments in Diagnosis and Therapy
Özdemır, Ö. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102204 · Cited by 2
Mohamed, R. A. E. H., Fakhr, A. E., & Baioumy, S. A. (2023) · Journal of Asthma · doi:10.1080/02770903.2023.2272813 · Cited by 2
Jung, J. H., Lee, S. M., Choi, Y. S., Cha, H. E., & Kim, S. T. (2023) · Acta Oto-Laryngologica · doi:10.1080/00016489.2023.2273405 · Cited by 2
Future Directions in Allergic Airways Diseases
Mall, T., Sharma, M., & Prasher, P. (2024) · Springer eBooks · doi:10.1007/978-981-97-1953-2_15 · Cited by 2
Allergen-specific Immunotherapy—Turning the Tables on the Immune System
Nowak-Wegrzyn, A. H., & Cox, L. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.09.001 · Cited by 2
Paolucci, M., Nilsson, F. A. M., Duda, A., Tusup, M., Diken, M., Kündig, T. M., & Johansen, P. (2025) · Allergy · doi:10.1111/all.16504 · Cited by 1
Self-citationImmunotherapy in Allergic and Mixed Rhinitis
Epstein, T., & Bernstein, D. I. (2025) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2025.09.008 · Cited by 2
Zhao, W., Gao, L., Chang, C., Hana, M., Satnarine, T., Brozyna, J., Jinlyu, S., Xu, G., & Wong, G. W. (2025) · Allergy medicine. · doi:10.1016/j.allmed.2025.100074 · Cited by 2
Novel Strategies for Allergy Immunotherapy
Reisacher, W. R., & Wang, A. (2013) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-013-0009-6 · Cited by 2
What will allergen immunotherapy look like in the future?
Nelson, H. S. (2012) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2012.05.021 · Cited by 1
Neue Entwicklungen bei antiallergischen Therapien und Therapiekonzepten
Röcken, M., Biedermann, T., & Renz, H. E. (2016) · Springer eBooks · doi:10.1007/978-3-642-37203-2_59 · Cited by 1
CLINICAL THERAPY RESEARCH IN ALLERGIC DISEASES
Campana, R., Valenta, R., Grundström, J., Hamsten, C., & van Hage, M. (2015) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814656337_0014 · Cited by 1
Antigen-targeted, synthetic vaccines for metastatic cancer
Qiu, Z., Diamond, D. C., Smith, K. A., Rosario, D., Miles, S., Obrocea, M., Kündig, T. M., & Bot, A. I. (2011) · Informa Healthcare eBooks · doi:10.3109/9781841848303.008 · Cited by 1
Self-citationKündig, T. M., Bot, A. I., & Senti, G. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0439-2_10 · Cited by 2
Self-citationAllergen Specific Immunotherapy (AIT)
Bandeira, T. L., Bandeira, I. M., Vasconcellos, J. C., dos Santos, A. M. E. D., Manuel, N. A. M., Mitre, P. P. S., Rebello, C. M., Braga, B. D. B., Filho, A. S., Sabrá, S., et al. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.20.1.2043 · Cited by 2
Allergen immunotherapy practice in India
Pandit, G., & Balachandra, B. (2023) · Journal of Pediatric Pulmonology · doi:10.4103/jopp.jopp_27_23 · Cited by 1
Metadata
- Authors
- Senti, G., Prinz Vavricka, B. M., Erdmann, I., Diaz, M. I., Markus, R., McCormack, S. J., Simard, J. J., Wüthrich, B., Crameri, R., Graf, N., Johansen, P., & Kündig, T. M.
- Affiliations
- University Hospital Zurich (CH)
- Unit for Experimental Immunotherapy, Department of Dermatology, and
- MannKind Corporation (United States) (US)
- Swiss Institute for Asthma and Allergy Research, 7270 Davos, Switzerland
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-11-18
- Volume
- 105
- Issue
- 46
- Pages
- 17908-17912
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2582048
- OpenAlex
- W1975755712
- Cited by
- 364
- References
- 26
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 14 · 2023: 22 · 2022: 26 · 2021: 18 · 2020: 21 · 2019: 12 · 2018: 18 · 2017: 23 · 2016: 24 · 2015: 19 · 2014: 35 · 2013: 30 · 2012: 26
- FWCI
- 12.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (114634, 310000)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- allergen immunotherapy, subcutaneous immunotherapy, grass pollen allergy, rhinoconjunctivitis, allergic rhinitis, IgE-mediated allergy, lymph node injection, treatment duration, treatment safety, medication adherence
- MeSH terms
- Adolescent, Adult, Aged, Allergens, Desensitization, Immunologic, Female, Humans, Hypersensitivity, Immunoglobulin E, Immune Tolerance, Injections, Intralymphatic, Injections, Subcutaneous, Male, Middle Aged, Pain, Skin Tests, Time Factors, Treatment Outcome, Anti-Allergic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.